Inventor · disambiguated record
David Fikstad
Also filed as: FIKSTAD DAVID · FIKSTAD DAVID T
6 granted patents·18 pending applications·1,154 citations·filing 1996–2020
90Inventor score
Files withLIPOCINE INC13THERATECH INC3LLPOCINE INC1TYAVANAGIMATT SHANTHAKUMAR1WATSON PHARMACEUTICALS INC1
Top patents by PatentIndex Score
24 records- 0198US6761903B2Clear oil-containing pharmaceutical compositions containing a therapeutic agentLIPOCINE INC·Filed 2001·Granted Jul 13, 2004·305 cites·122 claims
- 0298US5985317APressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agentsTHERATECH INC·Filed 1996·Granted Nov 16, 1999·410 cites·18 claims
- 0397US6365178B1Method of making pressure sensitive adhesive matrix patches for transdermal drug delivery using hydrophilic salts of drugs and hydrophobic pressure sensitive adhesive dispersionsWATSON PHARMACEUTICALS INC·Filed 2001·Granted Apr 2, 2002·112 cites·48 claims
- 0496US6458383B2Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparinLIPOCINE INC·Filed 2000·Granted Oct 1, 2002·139 cites·94 claims
- 0593US5952000AFatty acid esters of lactic acid salts as permeation enhancersTHERATECH INC·Filed 1997·Granted Sep 14, 1999·132 cites·20 claims
- 0682US5912009AFatty acid esters of glycolic acid and its saltsTHERATECH INC·Filed 1997·Granted Jun 15, 1999·56 cites·40 claims
- 0779US2010137271A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2009·Application pending·0 cites
- 0871US2020282061A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2020·Application pending·0 cites
- 0971US2018264117A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2017·Application pending·0 cites
- 1063US2003236236A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsFiled 2003·Application pending·0 cites
- 1161US2018125979A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2017·Application pending·0 cites
- 1260US2005096296A1Pharmaceutical compositions with synchronized solubilizer releaseFiled 2004·Application pending·0 cites
- 1360US2005096365A1Pharmaceutical compositions with synchronized solubilizer releaseFiled 2003·Application pending·0 cites
- 1459US2010136105A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2009·Application pending·0 cites
- 1558US2013052263A1Pharmaceutical compositions with synchronized solubilizer releaseLLPOCINE INC·Filed 2012·Application pending·0 cites
- 1658US2016184435A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2015·Application pending·0 cites
- 1757US2016015649A1Pharmaceutical compositions and dosage forms for administration of hydrophobic drugsLIPOCINE INC·Filed 2015·Application pending·0 cites
- 1857US2018099053A1Pharmaceutical compositions with synchronized solubilizer releaseLIPOCINE INC·Filed 2017·Application pending·0 cites
- 1956US2006003002A1Pharmaceutical compositions with synchronized solubilizer releaseLIPOCINE INC·Filed 2005·Application pending·0 cites
- 2054US2007281927A1Anti-inflammatory and analgesic compositions and related methodsTYAVANAGIMATT SHANTHAKUMAR·Filed 2006·Application pending·0 cites
- 2153US2020069805A1Pharmaceutical compositions with synchronized solubilizer releaseLIPOCINE INC·Filed 2019·Application pending·0 cites
- 2251US2016030583A1Pharmaceutical compositions with synchronized solubilizer releaseLIPOCINE INC·Filed 2015·Application pending·0 cites
- 2341US2003091620A1Transdermal drug delivery systems containing quaternary ammonium salts and methods of using the sameFiled 2002·Application pending·0 cites
- 2438US2002037311A1Transdermal delivery of lasofoxifeneFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Fikstad files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →